<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 15, 1997
REGISTRATION NO. 333-
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
---------------------
MEDPARTNERS, INC.
(Exact Name of Registrant as Specified in its Charter)
---------------------
<TABLE>
<S> <C> <C>
DELAWARE 8099 63-1151076
(State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer
Incorporation or Organization) Classification Code Number) Identification Number)
</TABLE>
---------------------
3000 GALLERIA TOWER, SUITE 1000, BIRMINGHAM, ALABAMA 35244-2331
(205) 733-8996
(Address, including Zip Code, and Telephone Number, including Area Code, of
Registrant's Principal Executive Offices)
J. BROOKE JOHNSTON, JR., ESQ.
SENIOR VICE PRESIDENT AND
GENERAL COUNSEL
MEDPARTNERS, INC.
3000 GALLERIA TOWER, SUITE 1000
BIRMINGHAM, ALABAMA 35244-2331
(205) 733-8996
(Name, Address, including Zip Code, and Telephone Number, including Area Code,
of Agent for Service)
COPIES TO:
<TABLE>
<C> <C>
FREDERICK W. KANNER, ESQ. ROBERT E. LEE GARNER, ESQ.
DEWEY BALLANTINE F. HAMPTON MCFADDEN, JR., ESQ.
1301 AVENUE OF THE AMERICAS HASKELL SLAUGHTER & YOUNG, L.L.C.
NEW YORK, NEW YORK 10019-6092 1200 AMSOUTH/HARBERT PLAZA
(212) 259-7300 1901 SIXTH AVENUE NORTH
BIRMINGHAM, ALABAMA 35203
(205) 251-1000
</TABLE>
---------------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: As soon as
practicable after this Registration Statement becomes effective.
If the only securities being registered on this form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [ ]
If any of the securities being registered on this form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [ ]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of earlier effective
registration statement for the same offering. [X] 333-30921
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
- ---------------
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
===============================================================================================================================
PROPOSED MAXIMUM PROPOSED MAXIMUM
TITLE OF EACH CLASS OF SECURITIES AMOUNT TO BE OFFERING PRICE PER AGGREGATE OFFERING AMOUNT OF
TO BE REGISTERED REGISTERED UNIT(1) PRICE(1) REGISTRATION FEE
- -------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Stock Purchase Units(2).......................
- ------------------------------------------------------------------------------------------------------------------------------
Stock Purchase Contracts(3)...................
- ------------------------------------------------------------------------------------------------------------------------------
Common Stock, par value $.001 per share
(including the Common Stock Purchase
Rights)(4)..................................
- ------------------------------------------------------------------------------------------------------------------------------
Total......................................... 100% $76,115,625 $23,066
==============================================================================================================================
</TABLE>
(1) Estimated solely for the purpose of calculating the registration fee
pursuant to Rule 457(o).
(2) There are being registered hereunder Stock Purchase Units having an
aggregate initial offering price of $76,115,625 (including Stock Purchase
Units subject to the underwriters' over-allotment option), representing
ownership of Stock Purchase Contracts and U.S. Treasury Securities.
(3) There are being registered hereunder that number of Stock Purchase
Contracts, representing rights to purchase Common Stock, forming a part of
the Stock Purchase Units.
(4) There are being registered hereunder such number of shares of Common Stock
as may be sold by the Registrant pursuant to the Stock Purchase Contracts.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE> 2
EXPLANATORY NOTE
This registration statement is being filed pursuant to Rule 462(b) under
the Securities Act of 1933, as amended ("Rule 462(b)"), to register an
additional 1,929,577 6 1/2% TAPS (Threshold Appreciation Price Securities) of
MedPartners, Inc., and includes the registration statement facing page, this
page, the signature page, an exhibit index, an accountants' consent and an
Exhibit 5 legal opinion. Pursuant to Rule 462(b), the contents of the
registration statement on Form S-3 (File No. 333-30921) of MedPartners, Inc.,
including the exhibits thereto, are incorporated by reference into this
registration statement.
1
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Birmingham, State of Alabama on September 15, 1997.
MEDPARTNERS, INC.
By: /s/ HAROLD O. KNIGHT, JR.
------------------------------------
Harold O. Knight, Jr.
Executive Vice President and Chief
Financial Officer
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed below by the following persons in the
capacities and on the dates indicated.
<TABLE>
<CAPTION>
SIGNATURE CAPACITY DATE
--------- -------- ----
<C> <S> <C>
* Chairman of the Board and September 15, 1997
- ----------------------------------------------------- Chief Executive Officer
Larry R. House and Director
/s/ HAROLD O. KNIGHT, JR. Executive Vice President and September 15, 1997
- ----------------------------------------------------- Chief Financial Officer
Harold O. Knight, Jr. (Principal Financial and
Accounting Officer)
* Director September 15, 1997
- -----------------------------------------------------
Richard M. Scrushy
* Director September 15, 1997
- -----------------------------------------------------
Larry D. Striplin, Jr.
* Director September 15, 1997
- -----------------------------------------------------
Charles W. Newhall, III
* Director September 15, 1997
- -----------------------------------------------------
Ted H. McCourtney
* Director September 15, 1997
- -----------------------------------------------------
Walter T. Mullikin, M.D.
* Director September 15, 1997
- -----------------------------------------------------
John S. McDonald, J.D.
* Director September 15, 1997
- -----------------------------------------------------
Rosalio J. Lopez, M.D.
</TABLE>
2
<PAGE> 4
<TABLE>
<CAPTION>
SIGNATURE CAPACITY DATE
--------- -------- ----
<C> <S> <C>
* Director September 15, 1997
- -----------------------------------------------------
C.A. Lance Picolo
* Director September 15, 1997
- -----------------------------------------------------
Roger L. Headrick
* Director September 15, 1997
- -----------------------------------------------------
Harry M. Jansen Kraemer, Jr.
*By: /s/ HAROLD O. KNIGHT, JR.
---------------------------------------------
Harold O. Knight, Jr.
As Attorney-in-Fact
</TABLE>
3
<PAGE> 5
EXHIBIT INDEX
<TABLE>
<CAPTION>
Sequentially
Numbered
Exhibit No. Description Page
- ----------- ----------- ------------
<S> <C> <C>
(5) Opinion of Haskell Slaughter & Young L.L.C. as to the
legality of the Securities.
(23)-1 Consent of Ernst & Young LLP.
(23)-2 Consent of Haskell Slaughter & Young L.L.C. (included in the
opinion filed as Exhibit (5)).
24 Powers of Attorney, filed as Exhibit 24 to the Company's
Registration Statement on Form S-3 (Registration No.
333-30921), are incorporated herein by reference.
</TABLE>
4
<PAGE> 1
EXHIBIT 5
[HASKELL SLAUGHTER & YOUNG, L.L.C. LETTERHEAD]
September 15, 1997
MedPartners, Inc.
3000 Galleria Tower, Suite 1000
Birmingham, Alabama 35244
Re: MedPartners, Inc.-
Registration Statement on Form S-3
(Our file No. 48367-073)
Gentlemen:
We have served as counsel for MedPartners, Inc., a Delaware
corporation (the "Company" or the "Issuer"), in connection with the
registration under the Securities Act of 1933, as amended, of an aggregate of
1,929,577 6 1/2% Threshold Appreciation Price Securities ("TAPS") pursuant to
the Company's Registration Statement on Form S-3 that has been filed pursuant
to Rule 462(b) under the Securities Act of 1933 (the "Registration Statement")
and into which the contents of the Company's Registration Statement on Form S-3
(File No. 333-30921) have been incorporated by reference. This opinion is
furnished to you pursuant to the requirements of Form S-3.
In connection with this opinion, we have examined and are familiar with
originals or copies (certified or otherwise identified to our satisfaction) of
such documents, corporate records and other instruments relating to the
incorporation of the Company and the authorization and issuance of the TAPS as
we have deemed necessary and appropriate.
Based upon the foregoing, and having regard for such legal
considerations as we have deemed relevant, it is our opinion that:
1. The TAPS have been duly authorized; and
<PAGE> 2
MedPartners, Inc.
September 11, 1997
Page 2
2. Upon issuance, sale and delivery of the TAPS as contemplated in
the Registration Statement, the TAPS will be legally issued, fully paid and
nonassessable.
We do hereby consent to the reference to our Firm under the heading
"Legal Matters" in the Prospectus which forms a part of the Registration
Statement, and to the filing of this opinion as an Exhibit thereto.
Very truly yours,
HASKELL SLAUGHTER & YOUNG, L.L.C.
By /s/ Robert E. Lee Garner
--------------------------------
Robert E. Lee Garner
<PAGE> 1
EXHIBIT (23)-1
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statement,
filed pursuant to Rule 462(b) under the Securities Act of 1933 to register an
additional 1,929,577 6 1/2% TAPS (Threshold Appreciation Price Securities), of
MedPartners, Inc. and in the related Prospectus of our report dated August 25,
1997 with respect to the consolidated financial statements of MedPartners,
Inc., included in its Current Report on Form 8-K dated August 27, 1997 and
filed with the Securities and Exchange Commission.
ERNST & YOUNG LLP
September 15, 1997
Birmingham, Alabama
